| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.96B | +45.1% |
| R&D Expense | $36.1M | -8.1% |
| SG&A Expense | $278.0M | +13.4% |
| Operating Income | -$126.1M | +96.6% |
| Pre-tax Income | -$1.18B | +73.2% |
| Income Tax | -$167.2M | -523.6% |
| Net Income | $449.9M | +115.8% |
| EPS (Basic) | $1.96 | +115.3% |
| EPS (Diluted) | $1.71 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $262.6M | +53.8% |
| Inventory | $501.3M | +24.7% |
| Current Assets | $2.16B | +25.2% |
| Total Assets | $22.61B | +13.6% |
| Current Liabilities | $1.30B | -2.4% |
| Long-term Debt | $14.70B | +13.9% |
| Total Liabilities | $17.63B | +12.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$421.4M | +45.0% |
| Investing Cash Flow | -$2.50B | +7.4% |
| Financing Cash Flow | $3.21B | -6.3% |
| +113.3% |
| Stockholders' Equity |
| $3.13B |
| +22.6% |